Liraglutide Injection
Product Images NDC 71288-563

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Liraglutide (NDC 71288-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL 2-pack Carton (Lira Carton 2pack)

Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL 2-pack Carton (Lira Carton 2pack)
This product is Liraglutide Injection containing 18 mg per 3 mL for single-patient use. It is essential to follow the directions provided by your healthcare professional and refer to the enclosed product literature. The ingredients include sodium phosphate dihydrate, propylene glycol, phenol, and water for injection. It should not be transferred to a syringe and needs to be refrigerated but not frozen. After the first use, store it below 86°F (30°C) and discard the pen after 30 days. The packaging is not child-resistant. It is recommended to contact your pharmacist if the seal is broken before the first use.*
FDA Label Image

Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL 3-pack Carton (Lira Carton 3pack V2)

Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL 3-pack Carton (Lira Carton 3pack V2)
The text provides detailed information about a medication containing liraglutide 6 mg in each mL. It is a sterile and nonpyrogenic solution for injection. The formulation includes inactive ingredients such as disodium phosphate, propylene glycol, phenol, and water for injection. The medication is dispensed in a pre-filled pen, with each pen containing 18 mg per 3 mL (6 mg per mL). It is designed for single-patient use and should not be transferred to a syringe. The pen can deliver 30 doses of 0.6 mg, 15 doses of 1.2 mg, or 10 doses of 1.8 mg. It should be refrigerated and not frozen, with post-first-use storage recommendations. The pen should be discarded after 30 days of first use. The container closure does not contain natural rubber latex. If the seal is broken, it is advised to contact a pharmacist.*
FDA Label Image

Structural Formula (Lira Fig 1)

Structural Formula (Lira Fig 1)
FDA Label Image

Figure 2 (Lira Fig 2)

Figure 2 (Lira Fig 2)
FDA Label Image

Figure 3 (Lira Fig 3)

Figure 3 (Lira Fig 3)
FDA Label Image

Figure 4 (Lira Fig 4)

Figure 4 (Lira Fig 4)
FDA Label Image

Flow Check Symbol (Lira Flow Check)

Flow Check Symbol (Lira Flow Check)
FDA Label Image

Figure A (Lira Ifu A)

Figure A (Lira Ifu A)
FDA Label Image

Figure B (Lira Ifu B)

Figure B (Lira Ifu B)
FDA Label Image

Figure C (Lira Ifu C)

Figure C (Lira Ifu C)
FDA Label Image

Figure D (Lira Ifu D)

Figure D (Lira Ifu D)
FDA Label Image

Figure E (Lira Ifu E)

Figure E (Lira Ifu E)
FDA Label Image

Figure F (Lira Ifu F)

Figure F (Lira Ifu F)
FDA Label Image

Figure G (Lira Ifu G)

Figure G (Lira Ifu G)
FDA Label Image

Figure H (Lira Ifu H)

Figure H (Lira Ifu H)
FDA Label Image

Figure I (Lira Ifu I)

Figure I (Lira Ifu I)
FDA Label Image

Figure J (Lira Ifu J)

Figure J (Lira Ifu J)
FDA Label Image

Figure K (Lira Ifu K)

Figure K (Lira Ifu K)
FDA Label Image

Figure L (Lira Ifu L)

Figure L (Lira Ifu L)
FDA Label Image

Figure M (Lira Ifu M V2)

Figure M (Lira Ifu M V2)
This text mentions different body parts such as upper arms, stomach, and thighs. It appears to be discussing areas that can be targeted for exercise or body improvement.*
FDA Label Image

Figure N (Lira Ifu N V2)

Figure N (Lira Ifu N V2)
FDA Label Image

Liraglutide Needle (Lira Ifu Needle)

Liraglutide Needle (Lira Ifu Needle)
FDA Label Image

Figure O (Lira Ifu O V2)

Figure O (Lira Ifu O V2)
FDA Label Image

Figure P (Lira Ifu P V2)

Figure P (Lira Ifu P V2)
FDA Label Image

Liraglutide Injection Pen (Lira Ifu Pen)

Liraglutide Injection Pen (Lira Ifu Pen)
This text appears to describe the components of a liraglutide injection pen. It includes a rubber stopper, pen cap, cartridge tip, cartridge, pointer, dose selector, and dose display. These components are essential for the proper use and administration of the injection pen.*
FDA Label Image

Figure Q (Lira Ifu Q V2)

Figure Q (Lira Ifu Q V2)
FDA Label Image

Figure R (Lira Ifu R)

Figure R (Lira Ifu R)
FDA Label Image

Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL Syringe Label (Lira Syringe V2)

Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL Syringe Label (Lira Syringe V2)
This is a description of a Liraglutide Injection with a concentration of 18 mg per 3 mL (6 mg per mL). It is specified for single-patient use only. The unique identification number (01)0037128856383 is also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.